Filter
631
Text search:
mandatory
Featured
Recommendations
42
New Publications
147
Language
Document type
No document type
349
Studies & Reports
113
Guidelines
91
Manuals
31
Strategic & Response Plan
26
Fact sheets
10
Training Material
6
Situation Updates
4
Infographics
1
Countries / Regions
India
44
Western and Central Europe
23
Global
22
South Africa
21
Kenya
19
Rwanda
15
Ethiopia
12
Ghana
12
Malawi
11
Eastern Europe
10
Sierra Leone
9
Nigeria
9
Uganda
9
Zambia
9
Tanzania
9
Ukraine
9
Syria
8
Latin America and the Carribbean
8
Nepal
7
Namibia
7
Asia
7
Philippines
5
Myanmar / Burma
5
East and Southern Africa
5
South–East Asia Region
5
Liberia
4
Lesotho
4
West and Central Africa
4
Middle East and North Africa
4
Africa
4
Congo, Democratic Republic of
3
Germany
3
Lebanon
3
Indonesia
3
Bangladesh
3
Brazil
3
Eastern Europe and Central Asia
3
Venezuela
3
Russia
3
Guinea
2
Zimbabwe
2
Haiti
2
Pakistan
2
Cambodia
2
North Macedonia
2
Hungary
2
Colombia
2
Botswana
2
Madagascar
2
Albania
2
Tajikistan
2
United Kingdom
2
Portugal
2
Senegal
1
Morocco
1
USA
1
Cameroon
1
Somalia
1
South Sudan
1
Jordan
1
Afghanistan
1
Turkey
1
Thailand
1
Ireland
1
Mozambique
1
Benin
1
Argentina
1
Eswatini/ Swaziland
1
Mexico
1
Bhutan
1
Poland
1
Palestine
1
Laos
1
Timor Leste/ East Timor
1
Estonia
1
Moldova
1
Iran
1
Kyrgyzstan
1
Kazakhstan
1
Georgia
1
Vietnam
1
Turkmenistan
1
Jamaica
1
Denmark
1
France
1
Maldives
1
Norway
1
Spain
1
Authors & Publishers
Publication Years
Category
Countries
233
Clinical Guidelines
50
Public Health
35
Key Resources
33
Women & Child Health
30
Pharmacy & Technologies
8
Capacity Building
6
Toolboxes
HIV
67
COVID-19
61
TB
44
Mental Health
40
Disability
25
AMR
20
Planetary Health
20
Caregiver
19
Conflict
16
Refugee
14
Rapid Response
13
NCDs
12
Ebola & Marburg
11
Pharmacy
9
Zika
7
Global Health Education
7
NTDs
7
Natural Hazards
6
Specific Hazards
6
Health Financing Toolbox
6
2.0 Rapid Response
5
Social Ethics
3
Polio
2
Cholera
1
The power of the Global Drug Policy Index lies in its key objective: to score and
rank how countries are faring in different areas of drug policy as identified in the
UN report ‘What we have learned over the last ten years: A summary of knowledge
acquired and produced by the UN system on drug-r
...
Drinking-water quality regulations and standards developed or revised in accordance with this guidance will reflect the best practices identified in the WHO Guidelines for Drinking-water Quality to most effectively protect public health. Moreover, the regulations and standards will consider local ne
...
2nd edition. The 2018 Roadmap incorporates an additional critical population: adolescents. Despite making up 1 in 6 of the world’s people, adolescents have been largely overlooked as global momentum to address TB has grown. Spanning the ages of 10–19 years, adolescents are both at risk of TB and
...
The 2021 Report examines country health spending patterns and trends over the past 20 years, before the COVID-19 pandemic, with greater focus on public spending on health. The report also presents spending on primary health care, preliminary health expenditure in 2020 for a small set of countries (i
...
Produced by Training and Research Support Centre for the Regional Network for Equity in Health in east and southern Africa (EQUINET), March 20, 2020.
This brief summarises and provides links to official, scientific and other resources to support an understanding of and individual to regional level
...
Key Recommendations for an Inclusive Urban Agenda
In this version of the compendium, each guidance is coded using the International Classification of Health Interventions (ICHI).
The compendium provides a systematic compilation of published guidance from WHO and other UN organizations on health and environment. Guidance on policies and actions a
...
Antimicrobial resistance has become one of the most eminent threats to global health and a rising concern for healthcare specialists. All around the world, many common infections are becoming resistant to the antimicrobial medicines used to treat them, resulting in high morbidity and mortality with
...
PLOS ONE | www.plosone.org
September 2014 | Volume 9 | Issue 9 | e103657
Article published in: Journal of Intensive Care (2015) 3:16
UNAIDS / 2019 Guidance
In case of resistance to rifampicin, fluoroquinolones become the preferred category of second-line drugs. Unfortunately, quinolone-resistant strains of Mycobacterium leprae have also been reported in several countries, probably due to the extensive use of quinolones for treating several types of inf
...
Links to the Humanitarian Charter and international law
